Seeking Alpha

Regeneron Pharmaceuticals (REGN +2.8%) is added to Bank of America's "U.S. 1 List," calling the...

Regeneron Pharmaceuticals (REGN +2.8%) is added to Bank of America's "U.S. 1 List," calling the company one of its top biotech picks for 2012. The firm says it sees upside to its above-consensus 2012 Eylea sales forecast of $350M, stemming from positive physician sentiment toward dosing frequency advantages for the eye treatment.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs